NAMPT Monoclonal Antibody (C8), Invitrogen™
Mouse Monoclonal Antibody
Manufacturer: Fischer Scientific
The price for this product is unavailable. Please request a quote
Antigen
NAMPT
Concentration
1 mg/mL
Classification
Monoclonal
Form
Liquid
Regulatory Status
RUO
Formulation
PBS with 50% glycerol and 0.05% Proclin 300, pH 7.4
Gene Alias
1110035O14Rik, AI314458, AI480535, DKFZp666B131, EC 2.4.2.12, hypothetical protein, MGC117256, NAmPRTase, NAMPT, nampt1, nampta, NAMPTP1, Nicotinamide phosphoribosyltransferase, nicotinamide phosphoribosyltransferase 1, nicotinamide phosphoribosyltransferase a, nicotinamide phosphoribosyltransferase pseudogene 1, PBEF, Pbef1, pre-B cell-enhancing factor, pre-B-cell colony enhancing factor 1, pre-B-cell colony-enhancing factor 1, Pre-B-cell colony-enhancing factor 1 homolog, pre-B-cell colony-enhancing factor 1 precursor, VF, VISFATIN
Gene Symbols
NAMPT
Isotype
IgG2b κ
Purification Method
Protein A/G
Gene
NAMPT
Clone
C8
Applications
Immunocytochemistry, Immunohistochemistry (Paraffin), Western Blot
Conjugate
Unconjugated
Host Species
Mouse
Target Species
Human, Mouse, Porcine
Gene Accession No.
P43490, Q52I78, Q99KQ4
Gene ID (Entrez)
10135, 59027, 595123
Immunogen
Recombinant Human VF protein, Met1-His491 (Accession #P43490)
Primary or Secondary
Primary
Content And Storage
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Related Products
Description
- Visfatin, also known as pre-B cell colony-enhancing factor, is an adipocytokine that is abundantly secreted by visceral adipose tissue, with insulin mimetic effects
- Visfatin mimics insulin signaling by binding to the insulin receptor and reducing glucose release from liver cells, while stimulating glucose utilization in adipocytes and myocytes
- Visfatin is also invoved in enhancement of cell proliferation, biosynthesis of nicotinamide mono-and dinucleotide and glucose homeostasis.